Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Kalow

Showing results (161-170 of 188) with videos related to

Pageof 19
Sort By:
Clinical Pharmacology and Therapeutics|January 1, 1995
Low CYP1A2 activity in rural Shona children of ZimbabweC M Masimirembwa, M Beke, J A Hasler, et al.
Clinical Pharmacology and Therapeutics|June 1, 1991
Caffeine as a metabolic probe: validation of its use for acetylator phenotypingB K Tang, D Kadar, L Qian, et al.
Journal of Chromatography|December 9, 1988
High-performance liquid chromatographic analysis of desferrioxamine. Pharmacokinetic and metabolic studiesT P Kruck, K Teichert-Kuliszewska, E Fisher, et al.
Canadian Journal of Physiology and Pharmacology|November 1, 1989
Haloperidol reduction can be assayed in human red blood cellsT Inaba, W Kalow, T Someya, et al.
Annals of Internal Medicine|August 1, 1986
Differences in metabolism of sulfonamides predisposing to idiosyncratic toxicityN H Shear, S P Spielberg, D M Grant, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 1, 1993
Human hepatic cytochrome P450 2D6-like activity in nonhuman primates: catalytic characterization in vitroD Wu, S V Otton, P Morrow, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 1, 1972
Existence of phospholipid bilayer structure in the inner membrane of mitochondriaJ C Hsia, W L Chen, R A Long, et al.
Biochemical and Biophysical Research Communications|September 5, 1972
Synthesis of spin labelled 2,4-dinitrophenols and their activities in the uncoupling of oxidative phosphorylation in rat liver mitochondriaJ C Hsia, W L Chen, L T Wong, et al.
Clinical Pharmacology and Therapeutics|October 23, 1997
Paroxetine potentiates the central nervous system side effects of perphenazine: contribution of cytochrome P4502D6 inhibition in vivoV Ozdemir, C A Naranjo, N Herrmann, et al.
Molecular Pharmacology|July 1, 1991
Neuronal cytochrome P450IID1 (debrisoquine/sparteine-type): potent inhibition of activity by (-)-cocaine and nucleotide sequence identity to human hepatic P450 gene CYP2D6R F Tyndale, R Sunahara, T Inaba, et al.
Pageof 19

Showing results (161-170 of 188) with videos related to

Sort By:
Pageof 19
Clinical Pharmacology and Therapeutics|January 1, 1995
Low CYP1A2 activity in rural Shona children of ZimbabweC M Masimirembwa, M Beke, J A Hasler, et al.
Clinical Pharmacology and Therapeutics|June 1, 1991
Caffeine as a metabolic probe: validation of its use for acetylator phenotypingB K Tang, D Kadar, L Qian, et al.
Journal of Chromatography|December 9, 1988
High-performance liquid chromatographic analysis of desferrioxamine. Pharmacokinetic and metabolic studiesT P Kruck, K Teichert-Kuliszewska, E Fisher, et al.
Canadian Journal of Physiology and Pharmacology|November 1, 1989
Haloperidol reduction can be assayed in human red blood cellsT Inaba, W Kalow, T Someya, et al.
Annals of Internal Medicine|August 1, 1986
Differences in metabolism of sulfonamides predisposing to idiosyncratic toxicityN H Shear, S P Spielberg, D M Grant, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 1, 1993
Human hepatic cytochrome P450 2D6-like activity in nonhuman primates: catalytic characterization in vitroD Wu, S V Otton, P Morrow, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 1, 1972
Existence of phospholipid bilayer structure in the inner membrane of mitochondriaJ C Hsia, W L Chen, R A Long, et al.
Biochemical and Biophysical Research Communications|September 5, 1972
Synthesis of spin labelled 2,4-dinitrophenols and their activities in the uncoupling of oxidative phosphorylation in rat liver mitochondriaJ C Hsia, W L Chen, L T Wong, et al.
Clinical Pharmacology and Therapeutics|October 23, 1997
Paroxetine potentiates the central nervous system side effects of perphenazine: contribution of cytochrome P4502D6 inhibition in vivoV Ozdemir, C A Naranjo, N Herrmann, et al.
Molecular Pharmacology|July 1, 1991
Neuronal cytochrome P450IID1 (debrisoquine/sparteine-type): potent inhibition of activity by (-)-cocaine and nucleotide sequence identity to human hepatic P450 gene CYP2D6R F Tyndale, R Sunahara, T Inaba, et al.
Pageof 19